NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/27/2026
Back to search
Official data from USPTO
CANCERLINQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANCERLINQ
ST13
US500000085524713Class
42, 44
Filing
85524713
Registration
4960466
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
05/19/2026
Trademark type
Word
Nice classes
42, 44
Filing date
01/25/2012
Registration date
05/17/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/27/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/18/2016
First use in commerce
03/18/2016
Drawing code
4
Owner type
16
Owner location
CAMBRIDGE, MA, US
Examiner
MONINGHOFF, KIM TERESA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CANCERLINQ LLC
American Society of Clinical Oncology, Inc.
Representatives
Christopher A. Proskey BROWNWINICK LAW FIRM
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; providing quality assurance services in the field of healthcarecollectingcomparinganalyzing of patient-level medical and clinical healthcare quality data and preparing reports in connection therewith for the purpose of analyzing the quality of cancer care and treatment
Class 44
Providing information in the field of neoplastic disease preventionscreeningdiagnosis and treatment for use by physicians and other health care providers in the field of neoplastic diseases; providing patient information in the field of neoplastic diseases
Publications
History of USPTO decisions and trademark events.
60 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/27/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/27/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/27/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
02/20/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/17/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/31/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/25/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/25/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/25/2021
E815
TEAS SECTION 8 & 15 RECEIVED
08/24/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/17/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/17/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/10/2016
IUAF
USE AMENDMENT FILED
04/06/2016
EISU
TEAS STATEMENT OF USE RECEIVED
04/06/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/15/2016
EX1G
SOU EXTENSION 1 GRANTED
03/12/2016
EXT1
SOU EXTENSION 1 FILED
02/24/2016
EEXT
SOU TEAS EXTENSION RECEIVED
02/24/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/25/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2015
PUBO
PUBLISHED FOR OPPOSITION
06/30/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/26/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/14/2015
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/11/2014
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/11/2014
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/09/2013
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/03/2013
ATRV
ATTORNEY REVIEW COMPLETED
02/19/2013
DPCC
DIVISIONAL PROCESSING COMPLETE
02/19/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/13/2013
DRRR
DIVISIONAL REQUEST RECEIVED
01/29/2013
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/29/2013
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/29/2012
GNSL
LETTER OF SUSPENSION E-MAILED
11/29/2012
CNSL
SUSPENSION LETTER WRITTEN
11/29/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2012
ALIE
ASSIGNED TO LIE
11/16/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/08/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2012
GNRT
NON-FINAL ACTION E-MAILED
05/08/2012
CNRT
NON-FINAL ACTION WRITTEN
05/08/2012
DOCK
ASSIGNED TO EXAMINER
05/03/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
01/31/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2012
NWAP
NEW APPLICATION ENTERED
01/28/2012
Continuous trademark protection
Get notified about every new filing that threatens CANCERLINQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.